Data powered by Alphabet Inc.
Ajanta Pharmaceuticals
AJANTPHARM
₹ 3,097.82
- ₹ 59.92
-1.89%
Ajanta Pharmaceuticals Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | -1.89% | 6,009 |
| Weekly | -4.22% | 2,75,625 |
| Monthly | 1.07% | 24,97,502 |
Ajanta Pharmaceuticals Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| AJANTPHARM | -1.89% | -4.22% | 1.07% |
| Index | - | - | - |
| Peer Avg. | 1.27% | -2.59% | 5.15% |
*Avg of index constituents
Ajanta Pharmaceuticals Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| AJANTPHARM | 14.38 | 4.80 | 14.89 | 23.28 | 29.71 | 0.81 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 38.60 | 4.35 | 13.48 | 12.96 | 16.49 | 0.78 |
*Avg of index constituents
Ajanta Pharmaceuticals Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 15.57% | 7.77% | 23.28% | 29.71% |
| FY '20-21 | 17.72% | 46.48% | 24.33% | 33.10% |
| FY '19-20 | 24.91% | 16.73% | 19.24% | 27.23% |
Ajanta Pharmaceuticals Shareholding Pattern
Promoters : 70.48%
FII : 8.64%
DII : 12.74%
Public : 8.14%
Others : 0%
Ajanta Pharmaceuticals Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 3,240.82 | 2,330.72 | 1,037.80 | 716.27 |
| FY '20-21 | 2,804.14 | 1,846.40 | 1,022.51 | 664.75 |
| FY '19-20 | 2,392.14 | 1,784.10 | 746.25 | 454.42 |
All values are in crores
Ajanta Pharmaceuticals Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| AJANTPHARM | 3,240.82 | 2,330.72 | 1,037.80 | 716.27 |
| SUVENPHAR | 1,320.22 | 738.22 | 722.09 | 485.40 |
| JBCHEPHARM | 2,307.06 | 1,781.39 | 565.10 | 373.52 |
All values are in crores
Ajanta Pharmaceuticals Share Price
Ajanta Pharma Limited is an Indian company primarily engaged in the development, manufacture and distribution of ready-made specialty medicines. The company's marketing network operates in domestic and international markets. The company produces a wide range of specialty products targeting different therapeutic segments for patient care and tailored to each market area in which it operates. The generic sea trade is spread across India and about 30 developing countries in Africa, Southeast Asia and West Asia and the Commonwealth of Independent States (CIS). Its product range includes advanced technology products. The company has also made significant investments in its research and development (R&D) facilities.
Ajanta Pharmaceuticals FAQs
How to Buy Ajanta Pharmaceuticals Share?
To purchase Ajanta Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Ajanta Pharmaceuticals (ticker symbol: AJANTPHARM) on the trading platform provided by your broker and purchase the shares.
What's Ajanta Pharmaceuticals share price today?
The stock price of Ajanta Pharmaceuticals as of 20 Sep 2024 is ₹3,097.82
What is the Market Cap of Ajanta Pharmaceuticals?
Market capitalisation represents the total market value of a company's outstanding shares. As of 20 Sep 2024, Ajanta Pharmaceuticals (ticker symbol: AJANTPHARM) has a market capitalisation of approximately ₹1,50,92,50,26,332.25
What is the PE and PB ratio of Ajanta Pharmaceuticals?
Ajanta Pharmaceuticals Ltd's price-to-book ratio as of 20 Sep 2024 is 4.804647, reflecting the market's valuation compared to its asset value. As of 20 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 14.380548, indicating the market values the company at around ₹14.38 for every ₹1 of earnings
What is the 52 Week High and Low of Ajanta Pharmaceuticals Share?
Ajanta Pharmaceuticals Ltd (AJANTPHARM) hit its 52-week high at ₹3,459.84, and its 52-week low at { ₹1,145.60}.